BETHANY QUINN: Open Payments
NPI 1114105335 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$622 in 25 payments from 14 companies in 2025. Trend: 2023 $526 · 2024 $532 · 2025 $622
Food & beverage: $622
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 5 | $117 |
| GENZYME CORPORATION | 2 | $83 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Grifols USA, LLC | 2 | $58 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Azurity Pharmaceuticals, Inc. | 2 | $40 |
| Inspire Medical Systems, Inc. | 1 | $38 |
| Lilly USA, LLC | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
Products named: DUPIXENT, TERLIVAZ, Prolastin-C Liquid, Sunosi, HORIZANT, INSPIRE, ZEPBOUND, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
